Surgery for early stage non-small cell lung cancer.

Lung cancer accounts for 28.2% of all cancer-related deaths in the United States. Most patients present with advanced-stage disease, with only 15% having disease confined to the lung. Surgical resection is the optimal treatment for Stage I and II non-small cell lung cancer. Pre-resection staging includes various radiographic modalities, including PET scan and mediastinoscopy. Survival and local recurrence statistics favor full anatomic lobar resection over sublobar resection, although cases must be judged individually. Lobectomy via thoracoscopic approach appears to have equivalent outcome as lobectomy via thoracotomy. Characteristics of the counseling physician and the hospital volume at which the surgery is performed can also influence outcome. After surgical resection, stage IA patients have about 70% 5-year survival, but this falls below 50% for stage IIB patients. Methods that identify early-stage lung cancer patients at greatest risk for recurrence are needed to identify patients who may benefit from additional therapies.

[1]  T. British,et al.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. , 2001, Thorax.

[2]  P. Thomas,et al.  Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1990, The Annals of thoracic surgery.

[3]  M. Socinski,et al.  Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer. , 2000, Chest.

[4]  P. Corcoran,et al.  Impact of revised stage classification of lung cancer on survival: a military experience. , 1999, Chest.

[5]  M. Mack,et al.  Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.

[6]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[7]  W. Smythe.  Treatment of stage I non-small cell lung carcinoma. , 2003, Chest.

[8]  A B de la Rivière,et al.  Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. , 2000, Chest.

[9]  J. Herndon,et al.  Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. , 2000, Radiology.

[10]  M E Burt,et al.  Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.

[11]  D. Margulies,et al.  Less than lobar resections for bronchogenic carcinoma. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.

[12]  D. Harpole,et al.  Predicting the sites of metastases from lung cancer using molecular biologic markers. , 2001, The Annals of thoracic surgery.

[13]  H. Groen,et al.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.

[14]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[16]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[17]  T. Naruke,et al.  What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery? , 2001, The Annals of thoracic surgery.

[18]  J. Deslauriers,et al.  Surgical therapy of early non-small cell lung cancer. , 2000, Chest.

[19]  M. Mack,et al.  Lobectomy--video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. , 1995, The Journal of thoracic and cardiovascular surgery.

[20]  R. Gibbons,et al.  Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). , 1996, Journal of the American College of Cardiology.

[21]  J. Birkmeyer,et al.  Hospital Volume and Surgical Mortality in the United States , 2002 .

[22]  C. Begg,et al.  The influence of hospital volume on survival after resection for lung cancer. , 2001, The New England journal of medicine.

[23]  J. Herndon,et al.  T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. , 2002, Radiology.

[24]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.

[25]  G. Colice,et al.  The physiologic evaluation of patients with lung cancer being considered for resectional surgery. , 2003, Chest.

[26]  P. Pairolero,et al.  Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. , 2002, The Annals of thoracic surgery.

[27]  R. Dowling,et al.  Prevalence of chronic pain after pulmonary resection by thoracotomy or video-assisted thoracic surgery. , 1994, The Journal of thoracic and cardiovascular surgery.

[28]  W. Richards,et al.  Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Tsuchiya,et al.  Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.

[30]  B. Temeck,et al.  Wedge Resection for Bronchogenic Carcinoma in High‐Risk Patients , 1992, Southern medical journal.

[31]  Teruaki Koike,et al.  Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. , 2003, The Journal of thoracic and cardiovascular surgery.

[32]  Ahmedin Jemal,et al.  Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.

[33]  T. D’amico,et al.  Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. , 2002, The Annals of thoracic surgery.

[34]  E. Perez.  Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer. , 1998, Chest.

[35]  M. Higashiyama,et al.  Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. , 1997, The Journal of thoracic and cardiovascular surgery.

[36]  R. Mckenna,et al.  Is lobectomy by video-assisted thoracic surgery an adequate cancer operation? , 1998, The Annals of thoracic surgery.

[37]  S. Swensen,et al.  Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study. , 1999, Radiology.

[38]  W. Warren,et al.  Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. , 1994, The Journal of thoracic and cardiovascular surgery.

[39]  W. Scott,et al.  Treatment of stage II non-small cell lung cancer. , 2003, Chest.

[40]  W. Walker,et al.  Long-term outcomes following VATS lobectomy for non-small cell bronchogenic carcinoma. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[41]  W F Taylor,et al.  Survival of patients surgically treated for stage I lung cancer. , 1981, The Journal of thoracic and cardiovascular surgery.

[42]  K. Esato,et al.  Video-assisted Thoracoscopic Lobectomy Achieves a Satisfactory Long-term Prognosis in Patients with Clinical Stage IA Lung Cancer , 2000, World Journal of Surgery.

[43]  L. Faber,et al.  Segmental resection for lung cancer. A fifteen-year experience. , 1973, The Journal of thoracic and cardiovascular surgery.